• 1
    Mazana J, Arino MR. Charles Robert Richet and some milestones in the history of allergies. J Investig Allergol Clin Immunol 1991; 1: 93100.
  • 2
    Cohen SG, Zelaya-Quesada M. Portier, Richet, and the discovery of anaphylaxis: a centennial. J Allergy Clin Immunol 2002; 110: 3316.
  • 3
    Ishizaka K, Ishizaka T, Hornbrook MM. Physico-chemical properties of human reaginic antibody. IV. Presence of a unique immunoglobulin as a carrier of reaginic activity. J Immunol 1966; 97: 7585.
  • 4
    Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, Moneret-Vautrin A, Niggemann B, Rance F. The management of anaphylaxis in childhood: position paper of the European academy of allergology and clinical immunology. Allergy 2007; 62: 85771.
  • 5
    Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 4669.
  • 6
    Strait RT, Morris SC, Finkelman FD. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc gamma RIIb cross-linking. J Clin Invest 2006; 116: 83341.
  • 7
    Strait RT, Morris SC, Yang M, Qu XW, Finkelman FD. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 2002; 109: 65868.
  • 8
    Oettgen HC, Martin TR, Wynshaw-Boris A, Deng C, Drazen JM, Leder P. Active anaphylaxis in IgE-deficient mice. Nature 1994; 370: 36770.
  • 9
    Khodoun MV, Strait R, Armstrong L, Yanase N, Finkelman FD. Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis. Proc Natl Acad Sci U S A 2011; 108: 124138.
  • 10
    Khan BQ, Kemp SF. Pathophysiology of anaphylaxis. Curr Opin Allergy Clin Immunol 11: 31925.
  • 11
    Hompes S, Kˆhli A, Nemat K, Scherer K, Lange L, RuÎff F, Rietschel E, Reese T, Szepfalusi Z, Schwerk N, Beyer K, Hawranek T, Niggemann B, Worm M. Provoking allergens and treatment of anaphylaxis in children and adolescents – data from the anaphylaxis registry of German-speaking countries. Pediatr Allergy Immunol 2011; 22: 56874.
  • 12
    Simons FE, Ardusso LR, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, Ledford DK, Lockey RF, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY, Worm M. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12: 38999.
  • 13
    Simons FE, Ardusso LR, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011; 127: 587–93 e1–22.
  • 14
    Palosuo K, Varjonen E, Nurkkala J, Kalkkinen N, Harvima R, Reunala T, Alenius H. Transglutaminase-mediated cross-linking of a peptic fraction of omega-5 gliadin enhances IgE reactivity in wheat-dependent, exercise-induced anaphylaxis. J Allergy Clin Immunol 2003; 111: 138692.
  • 15
    Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol 2005; 6: 13542.
  • 16
    Echtenacher B, Mannel DN, Hultner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature 1996; 381: 757.
  • 17
    Biedermann T, Kneilling M, Mailhammer R, Maier K, Sander CA, Kollias G, Kunkel SL, Hultner L, Rˆcken M. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 2000; 192: 144152.
  • 18
    Harada S, Horikawa T, Ashida M, Kamo T, Nishioka E, Ichihashi M. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001; 145: 3369.
  • 19
    Gonzalez-Quintela A, Vidal C, Gude F. Alcohol, IgE and allergy. Addict Biol 2004; 9: 195204.
  • 20
    RuÎff F, Dugas-Breit S, Przybilla B. Stinging Hymenoptera and mastocytosis. Curr Opin Allergy Clin Immunol 2009; 9: 33842.
  • 21
    RuÎff F, Przybilla B, Bilo MB, Müller U, Scheipl F, Aberer W, Birnbaum J, Bodzenta-Lukaszyk A, Bonifazi F, Bucher C, Campi P, Darsow U, Egger C, Haeberli G, Hawranek T, Kˆrner M, Kucharewicz I, Kuchenhoff H, Lang R, Quercia O, Reider N, Severino M, Sticherling M, Sturm GJ, Wüthrich B. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase – a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 2009; 124: 104754.
  • 22
    Biedermann T, Rˆcken M. [Delayed appearance of symptoms in immediate hypersensitivity: type I sensitization to galactose-alpha-1,3-galactose]. Hautarzt 2012; 63(Suppl) 1769.
  • 23
    Commins SP, Satinover SM, Hosen J, Mozena J, Borish L, Lewis BD, Woodfolk JA, Platts-Mills TA. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 2009; 123: 42633.
  • 24
    Dˆlle S, Hompes S, Grünhagen J, Worm M. [Food-associated anaphylaxis: Data from the anaphylaxis registry]. Hautarzt 2012; 63: 2948.
  • 25
    Worm M, Hompes S. [The registry for severe allergic reactions in German-speaking countries. Recent data and perspectives]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012; 55: 3804.
  • 26
    Przybilla B, RuÎff F. Insect stings: clinical features and management. Dtsch Arztebl Int 2012; 109: 23848.
  • 27
    Przybilla B, RuÎff F. Hymenoptera venom allergy. J Dtsch Dermatol Ges 2010; 8: 11427; quiz 128–30.
  • 28
    Worm M, Edenharter G, RuÎff F, Scherer K, Pfohler C, Mahler V, Treudler R, Lang R, Nemat K, Kˆhli A, Niggemann B, Hompes S. Symptom profile and risk factors of anaphylaxis in Central Europe. Allergy 2012; 67: 6918.
  • 29
    Hohenadel M, Beyer K, Hompes S, Worm M. Auslˆserprofile anaphhylaktischer Reaktionen – Vom niedergelassenen Allergologen bis zum Notfalleinsatz. Allergo J 2011; 34: 607.
  • 30
    Worm M, Hompes S, Vogel N, Kirschbaum J, Zuberbier T. Care of anaphylaxis among practising doctors. Allergy 2008; 63: 15623.
  • 31
    Namork E, Faeste CK, Stensby BA, Egaas E, L¯vik M. Severe allergic reactions to food in Norway: a ten year survey of cases reported to the food allergy register. Int J Environ Res Public Health 2011; 8: 314455.
  • 32
    Sicherer SH, Sampson HA. Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 2007; 120: 491503; quiz 504–5.
  • 33
    Calvani M, Cardinale F, Martelli A, Muraro A, Pucci N, Savino F, Zappala D, Panetta V. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22: 8139.
  • 34
    Iribarren C, Tolstykh IV, Miller MK, Eisner MD. Asthma and the prospective risk of anaphylactic shock and other allergy diagnoses in a large integrated health care delivery system. Ann Allergy Asthma Immunol 2010; 104: 3717.
  • 35
    Brockow K, Ring J. Update on diagnosis and treatment of mastocytosis. Curr Allergy Asthma Rep 2011; 11: 2929.
  • 36
    Simons KJ, Simons FE. Epinephrine and its use in anaphylaxis: current issues. Curr Opin Allergy Clin Immunol 2010; 10: 35461.
  • 37
    Ring J, Brockow K, Duda D, Eschenhagen T, Fuchs T, Hutteger I, Kapp A, Klimek L, Müller U, Niggemann B, Pfaar O, Przybilla B, Rebien W, Rietschel E, RuÎff F, Schnadt S, Tryba M, Worm M, Sitter H, Schultze-Werninghaus G. Akuttherapie anaphylaktischer Reaktionen. Allergo J 2007; 16: 42034.
  • 38
    Chen W, Mempel M, Schober W, Behrendt H, Ring J. Gender difference, sex hormones, and immediate type hypersensitivity reactions. Allergy 2008; 63: 141827.
  • 39
    Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 2008; 101: 13943.
  • 40
    Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, Bellolio MF, Bergstralh EJ, Stead LG, Li JT. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008; 122: 11615.
  • 41
    Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993–1994 to 2004–2005. J Allergy Clin Immunol 2007; 120: 87884.
  • 42
    Helbling A, Hurni T, Mueller UR, Pichler WJ. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004; 34: 28590.
  • 43
    Beyer K, Eckermann O, Hompes S, Grabenhenrich L, Worm M. Anaphylaxis in an emergency setting – elicitors, therapy and incidence of severe allergic reactions. Allergy 2012; 67: 14516.
  • 44
    Grabenhenrich L, Hompes S, Gough H, RuÎff F, Scherer K, Pfohler C, Treudler R, Mahler V, Hawranek T, Nemat K, Kˆhli A, Keil T, Worm M. Implementation of anaphylaxis management guidelines: a register-based study. PLoS One 2012; 7(5): e35778.
  • 45
    Ring J, Beyer K, Dorsch A, Biedermann T, Fischer J, Friedrichs F, Gebert N, Gieler U, Grosber M, Jakob T, Klimek L, Kugler C, Lange L, Pfaar O, Przybilla B, Reese I, Rietschel E, Schallmeyer S, Schnadt S, Szczepanski R, Worm M, Brockow K. Anaphylaxie-Schulung – ein neues Behandlungsprogramm zur terti‰ren Krankheitspr‰vention nach Anaphylaxie. Allergo J 2012; 21: 96102.